Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
1990-10-11
pubmed:abstractText
Complement component C3a is an anaphylatoxin known to induce plasma exudation and smooth muscle contraction in tissues. The effects on inflammatory effector leukocytes, however, are poorly defined and controversial, being at best weak and occurring at very high C3a concentrations. Here, we examined the effect of C3a upon mediator release from human basophils, with and without pretreatment with interleukin 3 (IL-3), a hematopoietic growth factor recently found to profoundly modify the basophil response to various cell agonists. In the absence of cytokines, C3a, even at a concentration of 1 microM, was ineffective or only weakly stimulatory for basophil mediator release. However, when basophils were pretreated with IL-3 at concentrations of only 0.01-1 unit/ml, they became responsive to C3a, releasing large amounts of histamine and also generating leukotrienes. Surprisingly, almost optimal effects occurred with even very low C3a concentrations (1 nM). Another hematopoietic growth factor, granulocyte/macrophage-colony-stimulating factor (GM-CSF), was also found to render basophils capable of responding to C3a, but the effect was weaker than that of IL-3. C3a-induced histamine release and leukotriene generation occurred rapidly in IL-3-primed cells, being complete after 0.5 and 2 min, respectively. The rapid and strong degranulation response, occurring at very low concentrations of C3a, suggests the presence of a high-affinity C3a receptor on basophils, which might be inducible by cytokines. Our results demonstrate that, depending on the presence of IL-3 or GM-CSF, C3a is a potent basophil activator, and such a phenomenon could be of relevance in various inflammatory processes, especially hypersensitivity reactions.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-1238393, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2428673, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2460553, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2473127, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2473472, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2474054, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2478657, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2479603, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2560275, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-2582257, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-3052279, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-342601, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-3492446, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-3540127, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-358800, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-4114148, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-4121926, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-4383923, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-6170591, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-6339618, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-6800960, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-6977086, http://linkedlifedata.com/resource/pubmed/commentcorrection/1697689-89118
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6813-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a.
pubmed:affiliation
Institute of Clinical Immunology, Inselspital, CH-3010 Bern, Switzerland.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, Non-P.H.S.